文献速递消化、代谢与肾脏急症儿科与产科急症

非流行区旅行者疟疾与登革热预测评分系统

Scoring systems for prediction of malaria and dengue fever in non-endemic areas among travellers arriving from tropical and subtropical areas.
PubMed 文献 · Emerg Med J · 2024-03-21
一句话结论从热带返回发热者,疟疾评分结合撒哈拉以南非洲旅行史、血小板减少、贫血和体温≥39.5°C;登革热评分结合白细胞减少、肌痛和皮疹;评分≥3分敏感性>80%。

该横断面研究纳入2015-2020年瑞典斯德哥尔摩卡罗林斯卡大学医院收治的从热带/亚热带地区返回后2个月内发热的成人和儿童,前瞻性和回顾性收集症状和实验室数据。共纳入2113名成人(18-94岁)和202名儿童(1-17岁),血涂片确诊疟疾112例(4.8%),PCR/血清学登革热阳性90例(3.9%)。通过后退消除回归分别建立疟疾和登革热评分系统(0-7分),评分≥3分时疟疾敏感性和特异性均>80%,登革热特异性>90%;登革热AUC成人0.92(95%CI 0.90-0.95)、儿童0.95(95%CI 0.88-1.0),疟疾AUC成人0.93(95%CI 0.91-0.96)、儿童0.88(95%CI 0.78-0.99)。评分系统为非流行区热带发热的结构化评估提供新工具,并突出与潜在严重病因相关的临床体征以指导微生物检查需求。

要点

  • 从撒哈拉以南非洲返回的发热患者,若同时出现血小板减少、贫血和体温≥39.5°C,疟疾可能性更高。
  • 从亚洲或南美洲/拉丁美洲返回后出现白细胞减少、肌肉疼痛和皮疹,提示登革热高概率。
  • 疟疾和登革热评分系统均为0-7分,评分≥3分时疟疾敏感性和特异性均>80%,登革热特异性>90%。
  • 登革热评分AUC成人0.92(95%CI 0.90-0.95)、儿童0.95(95%CI 0.88-1.0);疟疾评分AUC成人0.93(95%CI 0.91-0.96)、儿童0.88(95%CI 0.78-0.99)。
  • 研究采用bootstrap进行内部验证以处理乐观度和过拟合。

适用人群与场景

  • 2015-2020年在瑞典斯德哥尔摩卡罗林斯卡大学医院就诊的成人(18-94岁)和儿童(1-17岁),在前往热带/亚热带地区旅行后2个月内出现发热。

诊断标准与关键阈值

  • 疟疾评分:基于撒哈拉以南非洲旅行史、血小板减少、贫血和体温≥39.5°C等预测因子构建,总分0-7分,评分≥3分时敏感性和特异性均>80%。
  • 登革热评分:基于白细胞减少、肌肉疼痛和皮疹( after travelling to Asia or South/Latin America)等预测因子构建,总分0-7分,评分≥3分时特异性>90%。

研究设计与关键结果

  • 横断面研究纳入2113名成人(18-94岁)和202名儿童(1-17岁),血涂片确诊疟疾112例(4.8%),PCR/血清学登革热阳性90例(3.9%)。
  • 疟疾更可能见于有撒哈拉以南非洲旅行史且表现为血小板减少、贫血和体温≥39.5°C组合的患者。
  • 登革热高概率见于前往亚洲或南美洲/拉丁美洲旅行后出现白细胞减少、肌肉疼痛和皮疹的患者。
  • 疟疾和登革热评分系统总分均为0-7分;评分≥3分时,疟疾敏感性和特异性均>80%,登革热特异性>90%(儿童和成人)。
  • 登革热AUC:成人0.92(95%CI 0.90-0.95),儿童0.95(95%CI 0.88-1.0);疟疾AUC:成人0.93(95%CI 0.91-0.96),儿童0.88(95%CI 0.78-0.99)。
  • 采用bootstrap进行内部验证以处理乐观度和过拟合。

证据类型、等级与局限

  • 证据类型:横断面研究;数据前瞻性和回顾性收集;采用bootstrap进行内部验证以处理乐观度和过拟合。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 所提出的评分系统为非流行区热带发热患者的结构化评估提供新工具,并突出与潜在严重病因相关的临床体征,以指导微生物检查需求。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fever is a common symptom among travellers returning from tropical/subtropical areas to Europe, and promptly distinguishing severe illnesses from self-limiting febrile syndromes is important but can be challenging due to non-specific clinical presentation.

METHODS: A cross-sectional study enrolled adults and children who sought care during 2015-2020 at Karolinska University Hospital, Stockholm, Sweden with fever within 2 months after returning from travel to a tropical/subtropical area. Data on symptoms and laboratory parameters were prospectively and retrospectively collected. Two separate scoring systems for malaria and dengue were developed based on backward elimination regressions.

RESULTS: In total, 2113 adults (18-94 years) and 202 children (1-17 years) were included, with 112 (4.8%) confirmed malaria by blood thick smear and 90 (3.9%) PCR/serology dengue-positive cases. Malaria was more likely in a patient who had visited sub-Saharan Africa and presented with combination of thrombocytopenia, anaemia and fever ≥39.5°C. Leucopenia, muscle pain and rash after travelling to Asia or South/Latin America indicated high probability of dengue. Two scoring systems with points between 0 and 7 for prediction of malaria or dengue were created based on the above predictors. Scores ≥3 indicated >80% sensitivity and specificity for malaria and >90% specificity for dengue in children and adults (area under the curve (AUC) for dengue: 0.92 in adults (95% CI 0.90 to 0.95) and 0.95 in children (95% CI 0.88 to 1.0); AUC for malaria: 0.93 in adults (95% CI 0.91 to 0.96) and 0.88 in children (95% CI 0.78 to 0.99)). Internal validation of optimism and overfitting was managed with bootstrap.

CONCLUSION: The presented scoring systems provide novel tools for structured assessment of patients with tropical fever in a non-endemic area and highlight clinical signs associated with a potential severe aetiology to direct the need for microbial investigation.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Satarvandi D, van der Werff SD, Nauclér P, et al. Scoring systems for prediction of malaria and dengue fever in non-endemic areas among travellers arriving from tropical and subtropical areas. Emerg Med J. 2024. PMID: 38355290. doi:10.1136/emermed-2023-213296

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。